Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study
Digestive and Liver Disease · 2025-07 · 57 (7) · 1393-1402
DOI: 10.1016/j.dld.2025.04.021 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Digestive and Liver Disease, 2025-07. Verfasst von Daniela Pugliese und 59 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, L. Go A. Gemelli 8, 00168 Rome, Italy; UOC Pronto Soccorso,…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Gastrointestinal Agents, Machine Learning, Colitis, Ulcerative. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Takeda Pharmaceutical Company, Takeda EUCAN BU.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, L. Go A. Gemelli 8, 00168 Rome, Italy; UOC Pronto Soccorso, Medicina d'Urgenza e Medicina Interna, Ospedale Isola Tiberina Gemell…
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
- Institute of mechanics and adaptronics, TU Braunschweig.
- IBD Unit, Villa Sofia-Cervello Hospital, Palermo, Italy.
- Department of Biochemical and Clinical Science "L. Sacco" ASST Fatebenefratelli Sacco-University of Milan, Italy.
- Gastroenterology, Federico II University Hospital, Napoli, Campania, Italy.
Förderung
- Takeda Pharmaceutical Company
- Takeda EUCAN BU
Zitieren
APA
Pugliese, D., Privitera, G., Cersullo, N., Bordekar, H., Crispino, F., Mezzina, N., Pellegrini, L., Allocca, M., Laterza, L., Viola, A., Bertani, L., Soru, P., Scrivo, B., Barberio, B., Ricci, C., Balestrieri, P., Daperno, M., Pluchino, D., Rizzello, F., …, & Massari, A. (2025). Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study. Digestive and Liver Disease, 57(7), 1393-1402. https://doi.org/10.1016/j.dld.2025.04.021
Vancouver
Pugliese D, Privitera G, Cersullo N, Bordekar H, Crispino F, Mezzina N, et al. Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study. Digestive and Liver Disease. 2025;57(7):1393-1402. doi:10.1016/j.dld.2025.04.021
BibTeX
@article{Pugliese2025,
author = {Pugliese, Daniela and Privitera, Giuseppe and Cersullo, Nicola and Bordekar, Harsh and Crispino, Federica and Mezzina, Nicolò and Pellegrini, Lucienne and Allocca, Mariangela and Laterza, Lucrezia and Viola, Anna and Bertani, Lorenzo and Soru, Pietro and Scrivo, Barbara and Barberio, Brigida and Ricci, Chiara and Balestrieri, Paola and Daperno, Marco and Pluchino, Dario and Rizzello, Fernando and Scribano, Maria Lia and Sablich, Renato and Pastorelli, Luca and Manguso, Francesco and Variola, Angela and Di Sario, Antonio and Grossi, Laurino and Ribaldone, Davide Giuseppe and Biscaglia, Giuseppe and Buda, Andrea and Mocci, Giammarco and Viscido, Angelo and Di Paolo, Maria Carla and Onali, Sara and Rodino', Stefano and Coletta, Marina and Principi, Mariabeatrice and Miranda, Agnese and Amato, Arnaldo and Bezzio, Cristina and Petruzzellis, Carlo and Mazzuoli, Silvia and Festa, Stefano and Sartini, Alessandro and Checchin, Davide and Fanigliulo, Libera and Gallina, Sara and Cesarini, Monica and Bodini, Giorgia and Stradella, Davide and Spagnuolo, Rocco and Guidi, Luisa and Savarino, Edoardo and Cappello, Maria and Caprioli, Flavio and Costa, Francesco and Fries, Walter and Scaldaferri, Franco and Fiorino, Gionata and Castiglione, Fabiana and Massari, Alessandro},
title = {Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study},
journal = {Digestive and Liver Disease},
year = {2025},
volume = {57},
number = {7},
pages = {1393--1402},
doi = {10.1016/j.dld.2025.04.021}
}
EUVIMED